Oryzon Genomics Market Cap

Oryzon Genomics has a market cap or net worth of $235.01 million as of May 23, 2025. Its market cap has increased by 75.78% in one year.

Market Cap

235.01M

Enterprise Value

247.02M

Revenue

7.95M

Ranking

n/a

PE Ratio

n/a

Stock Price

$3.03

Market Cap Chart

Since December 14, 2015, Oryzon Genomics's market cap has increased from 134.67M to 235.01M, an increase of 74.51%. That is a compound annual growth rate of 6.07%.

Market Cap History

Date	Market Cap	% Change
May 22, 2025	239.63M	155.49%
Dec 31, 2024	93.79M	-21.99%
Dec 29, 2023	120.23M	-15.47%
Dec 30, 2022	142.23M	-11.82%
Dec 30, 2021	161.30M	-37.25%
Dec 31, 2020	257.03M	81.12%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Veradigm	747.23M
Nika Pharmaceuticals	672.83M
Tian'an Technology Group	591.73M
Elite Pharmaceuticals	544.82M
CytoDyn	485.21M
Glass House Brands	477.46M
Northwest Biotherapeutics	416.49M

Market Cap Rankings